relenza

Generic: zanamivir

Labeler: glaxosmithkline llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name relenza
Generic Name zanamivir
Labeler glaxosmithkline llc
Dosage Form POWDER
Routes
RESPIRATORY (INHALATION)
Active Ingredients

zanamivir 5 mg/1

Manufacturer
GlaxoSmithKline LLC

Identifiers & Regulatory

Product NDC 0173-0681
Product ID 0173-0681_244881b7-a19f-4409-abf7-2df6ad39c28e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021036
Listing Expiration 2026-12-31
Marketing Start 1999-09-22

Pharmacologic Class

Established (EPC)
neuraminidase inhibitor [epc]
Mechanism of Action
neuraminidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01730681
Hyphenated Format 0173-0681

Supplemental Identifiers

RxCUI
759471 759473
UNII
L6O3XI777I
NUI
N0000175524 N0000175436

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name relenza (source: ndc)
Generic Name zanamivir (source: ndc)
Application Number NDA021036 (source: ndc)
Routes
RESPIRATORY (INHALATION)
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 5 PACKAGE in 1 CARTON (0173-0681-01) / 4 POWDER in 1 PACKAGE
  • 5 PACKAGE in 1 CARTON (0173-0681-22) / 4 POWDER in 1 PACKAGE
source: ndc

Packages (2)

0173-0681-01 5 PACKAGE in 1 CARTON (0173-0681-01) / 4 POWDER in 1 PACKAGE 0173-0681-22 5 PACKAGE in 1 CARTON (0173-0681-22) / 4 POWDER in 1 PACKAGE

Ingredients (1)

zanamivir (5 mg/1)

Linked Drug Pages (1)

RELENZA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "244881b7-a19f-4409-abf7-2df6ad39c28e", "openfda": {"nui": ["N0000175524", "N0000175436"], "unii": ["L6O3XI777I"], "rxcui": ["759471", "759473"], "spl_set_id": ["d7c3bcc3-0c0d-4068-fd80-88cf54a376ef"], "pharm_class_epc": ["Neuraminidase Inhibitor [EPC]"], "pharm_class_moa": ["Neuraminidase Inhibitors [MoA]"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 PACKAGE in 1 CARTON (0173-0681-01)  / 4 POWDER in 1 PACKAGE", "package_ndc": "0173-0681-01", "marketing_start_date": "19990922"}, {"sample": false, "description": "5 PACKAGE in 1 CARTON (0173-0681-22)  / 4 POWDER in 1 PACKAGE", "package_ndc": "0173-0681-22", "marketing_start_date": "20070309"}], "brand_name": "RELENZA", "product_id": "0173-0681_244881b7-a19f-4409-abf7-2df6ad39c28e", "dosage_form": "POWDER", "pharm_class": ["Neuraminidase Inhibitor [EPC]", "Neuraminidase Inhibitors [MoA]"], "product_ndc": "0173-0681", "generic_name": "zanamivir", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RELENZA", "active_ingredients": [{"name": "ZANAMIVIR", "strength": "5 mg/1"}], "application_number": "NDA021036", "marketing_category": "NDA", "marketing_start_date": "19990922", "listing_expiration_date": "20261231"}